Notice of Intent to Sole Source - Intercept Pathogen Platelet Kits
Closed Special Notice Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- W81K0024Q0017
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Fort Bliss, Texas 79918, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice announces the Medical Readiness Contracting Office-West's intent to award a sole source contract to Cerus Corporation. The agency is the Department of the Army Medical Command.
The Special Notice is to provide INTERCEPT Pathogen Platelet Kits for government-owned equipment at William Beaumont Army Medical Center in Fort Bliss, Texas, from January 1, 2024 to September 30, 2028. While this is not a competitive proposal request, all responsible sources may submit capability statements or proposals for consideration for future requirements by December 5, 2023. The contract is projected under solicitation number W81K00-24-Q-0017. The NAICS code is 325413 with a size standard of 1,250 employees. Points of contact are provided for any questions.
Notice text
Notice of Intent to Sole Source The Medical Readiness Contracting Office-West, intends to award a sole source contract with Cerus Corporation for INTERCEPT Pathogen Platelet Kits for government owned equipment, under authority of Federal Acquisition Regulation, FAR 13.106-1(b)(i) Only one source reasonably available (e.g, urgency, exclusive licensing agreement, brand name or industrial mobilization), for William Beaumont Army Medical Center, Fort Bliss, Texas. The sole source contract will have a period of performance is 01 January 2024– 30 September 2028. The NAICS code 325413, size standard is 1,250 employees. This notice is neither a request for quotes nor a solicitation of offers; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency for future requirements. The solicitation number is W81K00-24-Q-0017 and is generated for the purposes of posting this notice of intent and the final Justification and Approval (J&A) document. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. All responses received, to include capability statements, within 5 days of the posting of this notice will be considered by the Government. A determination by the Government not to compete the interim purchase order based upon responses to this notice is solely within the discretion of the Government. Points of contact are Mr. Darryl O. Bryant, Contract Specialist, at darryl.o.bryant.civ@health.mil, and Ms. Emerita Torres, Contracting Officer, at emerita.torres.civ@health.mil
Notice history
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Sole Source Notice - Blood and Blood Products | Department of Veterans Affairs | No set-aside | |
| BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems | Defense Health Agency | Service-Disabled Veteran-Owned Small Business | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside | |
| Q301--Notice of Intent to Sole Source - Pathology Reference Lab Services - 528,528A8 | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity